ARTOS - Avelox in Routine Treatment of Complicated Skin and Skin Structure Infections.
Phase of Trial: Phase IV
Latest Information Update: 15 Nov 2012
At a glance
- Drugs Moxifloxacin (Primary)
- Indications Bacterial infections; Skin infections
- Focus Therapeutic Use
- Acronyms ARTOS
- Sponsors Bayer
- 02 Dec 2011 Primary endpoint identified as (clinical response rate) and (drug utilisation) as reported by ClinicalTrials.gov.
- 21 Nov 2011 Additional location added as reported by ClinicalTrials.gov.
- 28 Oct 2009 New trial record